Diwa, Baby Girl .
HRN: 27-43-94 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/18/2025
AMPICILLIN 250MG (VIAL)
07/18/2025
07/25/2025
IV
160
Q12H
1. NAMF ( Maternal UTI), 2. Live Term Neonate Delivered Cephalic Via NSVD AS 8,9 BS 39 Weeks , BW 3200grams, AGA, Thinly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes